9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Application of Sparse Linear Discriminant Analysis and Elastic Net for Diagnosis of IgA Nephropathy: Statistical and Biological Viewpoints

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background:

          IgA nephropathy (IgAN) is the most common primary glomerulonephritis diagnosed based on renal biopsy. Mesangial IgA deposits along with the proliferation of mesangial cells are the histologic hallmark of IgAN. Non-invasive diagnostic tools may help to prompt diagnosis and therapy. The discovery of potential and reliable urinary biomarkers for diagnosis of IgAN depends on applying robust and suitable models. Applying two multivariate modeling methods on a urine proteomic dataset were obtained from IgAN patients, and comparison of the results of these methods were the purpose of this study.

          Methods:

          Two models were constructed for urinary protein profiles of 13 patients and 8 healthy individuals, based on sparse linear discriminant analysis (SLDA) and elastic net (EN) regression methods. A panel of selected biomarkers with the best coefficients were proposed and further analyzed for biological relevance using functional annotation and pathway analysis.

          Results:

          Transferrin, α1-antitrypsin, and albumin fragments were the most important up-regulated biomarkers, while fibulin-5, YIP1 family member 3, prasoposin, and osteopontin were the most important down-regulated biomarkers. Pathway analysis revealed that complement and coagulation cascades and extracellular matrix-receptor interaction pathways impaired in the pathogenesis of IgAN.

          Conclusion:

          SLDA and EN had an equal importance for diagnosis of IgAN and were useful methods for exploring and processing proteomic data. In addition, the suggested biomarkers are reliable candidates for further validation to non-invasive diagnose of IgAN based on urine examination.

          Related collections

          Most cited references44

          • Record: found
          • Abstract: not found
          • Article: not found

          Variable Selection via Nonconcave Penalized Likelihood and its Oracle Properties

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The Adaptive Lasso and Its Oracle Properties

            Hui Zou (2006)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The properties of high-dimensional data spaces: implications for exploring gene and protein expression data.

              High-throughput genomic and proteomic technologies are widely used in cancer research to build better predictive models of diagnosis, prognosis and therapy, to identify and characterize key signalling networks and to find new targets for drug development. These technologies present investigators with the task of extracting meaningful statistical and biological information from high-dimensional data spaces, wherein each sample is defined by hundreds or thousands of measurements, usually concurrently obtained. The properties of high dimensionality are often poorly understood or overlooked in data modelling and analysis. From the perspective of translational science, this Review discusses the properties of high-dimensional data spaces that arise in genomic and proteomic studies and the challenges they can pose for data analysis and interpretation.
                Bookmark

                Author and article information

                Journal
                Iran Biomed J
                Iran. Biomed. J
                Iranian Biomedical Journal
                Pasteur Institute (Iran )
                1028-852X
                2008-823X
                November 2018
                : 22
                : 6
                : 374-384
                Affiliations
                [1 ]Department of Biostatistics and Epidemiology, Kermanshah University of Medical Sciences, School of Public Health, Kermanshah, Iran
                [2 ]Chronic Kidney Disease Research Center, Labbafinejad Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
                [3 ]Department of Biostatistics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
                [4 ]Urology-Nephrology Research Center, Labbafinejad Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
                [5 ]Department of Biostatistics and Epidemiology, School of Public Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
                [6 ]Department of Nephrology, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
                [7 ]Department of Pathology, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
                [8 ]Research Center for Environmental Determinants of Health (RCEDH), Kermanshah University of Medical Sciences, Kermanshah, Iran
                [9 ]Department of Biostatistics and Epidemiology, Faculty of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
                Author notes
                Corresponding Author: Shiva Kalantari Chronic Kidney Disease Research Center, Labbafinejad Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Tel.: (+98-21) 22594197; Fax: (+98-21) 22580201; E-mail: shiva.kalantari@ 123456sbmu.ac.ir
                Article
                IBJ-22-374
                10.29252/.22.6.374
                6305813
                29523019
                631a14d7-9c21-40c0-8d57-45a4f2deeb65
                Copyright: © Iranian Biomedical Journal

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License, ( http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 09 October 2017
                : 31 December 2017
                : 03 January 2017
                Categories
                Full Length

                biomarker,diagnosis,iga nephropathy,proteomics
                biomarker, diagnosis, iga nephropathy, proteomics

                Comments

                Comment on this article